Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps

NCT00005094 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1170

Enrollment

NIH

Sponsor class

Conditions

Colon Cancer
Rectal Cancer

Interventions

DRUG: celecoxib
OTHER: placebo

Sponsor

National Cancer Institute (NCI)